Fennec Pharmaceuticals In... (FENC)
6.78
-0.24 (-3.42%)
At close: Mar 03, 2025, 3:59 PM
6.77
-0.15%
After-hours: Mar 03, 2025, 04:00 PM EST
Fennec Pharmaceuticals Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 |
| PE Ratio | -18.58 | -10.15 | -6.56 | -9.85 | -10.36 | -12.22 | -21.32 | -54.55 | -197.15 | -54.44 | 63.21 | -19.05 | 20.48 | -10.86 | -12.24 | -2.71 | -2.51 | -0.72 | -0.59 | -0.8 | -0.6 | -0.62 | -0.6 | -4.03 |
| PEG Ratio | 0.50 | -0.24 | 0.55 | -0.48 | -0.49 | -1.15 | -0.19 | -0.21 | 2.73 | 0.25 | -0.49 | 0.09 | -0.13 | -0.82 | 0.16 | 0.37 | 0.04 | 0.04 | -0.02 | 0.03 | -0.22 | 0.16 | -0.00 | n/a |
| PS Ratio | 14.03 | 164.33 | n/a | 1.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.22M | 9.53M |
| PB Ratio | -25.65 | -98.19 | 7.26 | 6.07 | 10.87 | 5.67 | 5.61 | 42.61 | 237.09 | 193.23 | -80.16 | -19.84 | -799.43 | -17.25 | 90.83 | 12.08 | 2.37 | 1.81 | 0.56 | 0.21 | 0.24 | 0.38 | 0.15 | 137.80 |
| P/FCF Ratio | -17.39 | -13.97 | -8.05 | -11.32 | -14.25 | -15.44 | -41.26 | -71.62 | -69.78 | -69.72 | -52.77 | -32.85 | -29.74 | -44.05 | -7.87 | -3.41 | -2.51 | -1.02 | -0.91 | -1.13 | -0.68 | -0.65 | -0.48 | -5.13 |
| P/OCF Ratio | -17.39 | -13.97 | -8.05 | -11.32 | -14.25 | -15.44 | -41.26 | -71.62 | -69.78 | -69.72 | -52.77 | -32.85 | -29.74 | -44.05 | -7.87 | -3.41 | -2.52 | -1.02 | -0.92 | -1.16 | -0.68 | -0.72 | -0.54 | -5.26 |
| OCF/S Ratio | -0.81 | -11.76 | n/a | -91.74 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.07M | -1.81M |
| Debt / Equity Ratio | -2.66 | -9.69 | 0.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 1.26 |
| Quick Ratio | 3.27 | 5.67 | 13.54 | 13.39 | 6.11 | 14.02 | 17.28 | 9.88 | 2.16 | 1.35 | 0.55 | 0.32 | 0.98 | 0.55 | 1.80 | 2.27 | 6.82 | 1.24 | 5.01 | 14.59 | 2.76 | 8.55 | 18.92 | 0.91 |
| Current Ratio | 3.56 | 5.80 | 13.54 | 13.39 | 6.11 | 14.02 | 17.28 | 9.88 | 2.16 | 1.35 | 0.55 | 0.32 | 0.98 | 0.55 | 1.98 | 2.32 | 6.89 | 1.26 | 5.03 | 14.69 | 3.06 | 8.91 | 18.92 | 0.91 |
| Asset Turnover | 0.79 | 0.06 | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 |
| Interest Coverage | -3.76 | -23.1 | -136.69 | -1.99K | n/a | n/a | n/a | n/a | n/a | -1.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.35K | -1.67K | 21.22 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | 1.38 | 9.67 | -1.11 | -0.62 | -1.05 | -0.46 | -0.26 | -0.78 | -1.2 | -3.55 | -1.27 | 1.04 | -39.04 | 1.59 | -7.42 | -4.45 | -0.94 | -2.52 | -0.96 | -0.26 | -0.4 | -0.61 | -0.25 | -34.18 |
| Return on Assets (ROA) | -0.6 | -0.92 | -0.78 | -0.57 | -0.88 | -0.43 | -0.25 | -0.7 | -0.65 | -0.92 | 1.05 | -2.18 | 0.88 | -1.31 | -3.62 | -2.24 | -0.78 | -1.15 | -0.68 | -0.21 | -0.24 | -0.55 | -0.23 | -2.48 |
| Return on Capital (ROIC) | -0.66 | -1.01 | -0.83 | -0.62 | -1.1 | -0.49 | -0.26 | -0.8 | -3.45 | -4.69 | 1.33 | 0.73 | 28.65 | 0.94 | -7.79 | -3.83 | -0.96 | -1.6 | -0.71 | -0.23 | -0.27 | -0.66 | -0.27 | -9.81 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 94.08% | 94.40% | n/a | 100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.36M% | 100.00% |
| Net Profit Margin | -75.5% | -1.62K% | n/a | -10.54K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -371.51M% | -236.4M% |
| Pretax Profit Margin | -75.5% | -1.54K% | n/a | -10.65K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -371.51M% | -236.4M% |
| Operating Profit Margin | -60.09% | -1.47K% | n/a | -10.52K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -400.9M% | -237.63M% |
| FCF Margin | -80.67% | -1.18K% | n/a | -9.17K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -457.09M% | -185.91M% |
| EBITDA Margin | -58.18% | -1.47K% | n/a | -10.52K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -421.93M% | -383.85M% |